Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 650

1.

Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Piret J, Boivin G.

Clin Microbiol Rev. 2020 Feb 12;33(2). pii: e00105-19. doi: 10.1128/CMR.00105-19. Print 2020 Mar 18. Review.

PMID:
32051176
2.

Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.

Abed Y, Schibler M, Checkmahomed L, Carbonneau J, Venable MC, Fage C, Giannotti F, Goncalves AR, Kaiser L, Boivin G.

Antivir Ther. 2020 Feb 7. doi: 10.3851/IMP3344. [Epub ahead of print]

PMID:
32031540
3.

Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.

Zarrouk K, Pham VD, Piret J, Shi R, Boivin G.

Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.01910-19. doi: 10.1128/AAC.01910-19. [Epub ahead of print]

PMID:
32015044
4.

Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.

Pilaev M, Shen Y, Carbonneau J, Venable MC, Rhéaume C, Lavigne S, Couture C, Guarné A, Hamelin MÈ, Boivin G.

Vaccine. 2020 Feb 24;38(9):2122-2127. doi: 10.1016/j.vaccine.2020.01.047. Epub 2020 Jan 29.

PMID:
32007293
5.

Herpes simplex encephalitis in adult patients with MASP-2 deficiency.

Bibert S, Piret J, Quinodoz M, Collinet E, Zoete V, Michielin O, Menasria R, Meylan P, Bihl T, Erard V, Fellmann F, Rivolta C, Boivin G, Bochud PY.

PLoS Pathog. 2019 Dec 23;15(12):e1008168. doi: 10.1371/journal.ppat.1008168. eCollection 2019 Dec.

6.

Novel antiviral compounds and combination therapy for influenza viruses.

Boivin G, Rosa-Calatrava M, Lina B.

Virologie (Montrouge). 2019 Dec 1;23(6):325-328. doi: 10.1684/vir.2019.0802. No abstract available.

PMID:
31859255
7.

Novel antiviral compounds and combination therapy for influenza viruses.

Boivin G, Rosa-Calatrava M, Lina B.

Virologie (Montrouge). 2019 Dec 1;23(6):32-35. doi: 10.1684/vir.2019.0803. No abstract available.

PMID:
31859254
8.

Influenza virus epidemiology: a permanent vaccine challenge.

Boivin G, Lina B.

Virologie (Montrouge). 2019 Oct 1;23(5):271-276. doi: 10.1684/vir.2019.0788. No abstract available.

PMID:
31826848
9.

Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.

Baz M, M'hamdi Z, Carbonneau J, Lavigne S, Couture C, Abed Y, Boivin G.

Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4.

10.

Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development.

Dubois J, Pizzorno A, Cavanagh MH, Padey B, Nicolas de Lamballerie C, Uyar O, Venable MC, Carbonneau J, Traversier A, Julien T, Lavigne S, Couture C, Lina B, Hamelin MÈ, Terrier O, Rosa-Calatrava M, Boivin G.

Vaccines (Basel). 2019 Oct 30;7(4). pii: E164. doi: 10.3390/vaccines7040164.

11.

Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection.

Mandon ED, Pizzorno A, Traversier A, Champagne A, Hamelin ME, Lina B, Boivin G, Dejean E, Rosa-Calatrava M, Jawhari A.

Vaccine. 2020 Jan 10;38(2):278-287. doi: 10.1016/j.vaccine.2019.10.018. Epub 2019 Oct 18.

PMID:
31630939
12.

CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls.

Ramendra R, Isnard S, Lin J, Fombuena B, Ouyang J, Mehraj V, Zhang Y, Finkelman M, Costiniuk C, Lebouché B, Chartrand-Lefebvre C, Durand M, Tremblay C, Ancuta P, Boivin G, Routy JP.

Clin Infect Dis. 2019 Oct 14. pii: ciz1001. doi: 10.1093/cid/ciz1001. [Epub ahead of print]

PMID:
31608409
13.

Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.

Checkmahomed L, M'hamdi Z, Carbonneau J, Venable MC, Baz M, Abed Y, Boivin G.

J Infect Dis. 2020 Jan 1;221(1):63-70. doi: 10.1093/infdis/jiz418.

PMID:
31419295
14.

Bone remodeling and bone matrix quality before and after menopause in healthy women.

Farlay D, Bala Y, Rizzo S, Bare S, Lappe JM, Recker R, Boivin G.

Bone. 2019 Nov;128:115030. doi: 10.1016/j.bone.2019.08.003. Epub 2019 Aug 9.

PMID:
31404670
15.

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia.

Nicolas de Lamballerie C, Pizzorno A, Dubois J, Julien T, Padey B, Bouveret M, Traversier A, Legras-Lachuer C, Lina B, Boivin G, Terrier O, Rosa-Calatrava M.

Sci Rep. 2019 Aug 7;9(1):11493. doi: 10.1038/s41598-019-48013-7.

16.

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang ALS, Gillis HD, Martin I, Demczuk W, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy AE, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA.

Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23.

17.

The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors.

Abed Y, Fage C, Checkmahomed L, Begin G, Carbonneau J, Lague P, Boivin G.

Antiviral Res. 2019 Oct;170:104561. doi: 10.1016/j.antiviral.2019.104561. Epub 2019 Jul 16.

PMID:
31323237
18.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
19.

Antiviral Agents in Development for Zika Virus Infections.

Baz M, Boivin G.

Pharmaceuticals (Basel). 2019 Jun 29;12(3). pii: E101. doi: 10.3390/ph12030101. Review.

20.

Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.

Piret J, Schibler M, Pham VD, Hantz S, Giannotti F, Masouridi-Levrat S, Kaiser L, Goyette N, Alain S, Shi R, Boivin G.

J Infect Dis. 2019 Sep 13;220(8):1302-1306. doi: 10.1093/infdis/jiz298.

PMID:
31199457
21.

Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice.

Lê VB, Dubois J, Couture C, Cavanagh MH, Uyar O, Pizzorno A, Rosa-Calatrava M, Hamelin MÈ, Boivin G.

PLoS Pathog. 2019 Apr 9;15(4):e1007689. doi: 10.1371/journal.ppat.1007689. eCollection 2019 Apr.

22.

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.

Abed Y, Fage C, Lagüe P, Carbonneau J, Papenburg J, Vinh DC, Boivin G.

Emerg Infect Dis. 2019 Apr;25(4):838-840. doi: 10.3201/eid2504.181554.

23.

Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets.

Turgeon N, Hamelin MÈ, Verreault D, Lévesque A, Rhéaume C, Carbonneau J, Checkmahomed L, Girard M, Boivin G, Duchaine C.

Int J Environ Res Public Health. 2019 Feb 19;16(4). pii: E609. doi: 10.3390/ijerph16040609.

24.

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.

Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A, Roche M, Hamelin ME, Rhéaume C, Croze S, Escuret V, Poissy J, Lina B, Legras-Lachuer C, Textoris J, Boivin G, Rosa-Calatrava M.

Front Immunol. 2019 Jan 29;10:60. doi: 10.3389/fimmu.2019.00060. eCollection 2019.

25.

The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.

Canivet C, Uyar O, Rhéaume C, Piret J, Boivin G.

J Neurovirol. 2019 Jun;25(3):372-383. doi: 10.1007/s13365-019-00730-5. Epub 2019 Feb 13.

PMID:
30758810
26.

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes.

Del Campo J, Pizzorno A, Djebali S, Bouley J, Haller M, Pérez-Vargas J, Lina B, Boivin G, Hamelin ME, Nicolas F, Le Vert A, Leverrier Y, Rosa-Calatrava M, Marvel J, Hill F.

NPJ Vaccines. 2019 Jan 23;4:4. doi: 10.1038/s41541-019-0098-4. eCollection 2019.

27.

Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.

Piret J, Boivin G.

Antiviral Res. 2019 Mar;163:91-105. doi: 10.1016/j.antiviral.2019.01.011. Epub 2019 Jan 25. Review.

PMID:
30690043
28.

The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Dubois J, Traversier A, Julien T, Padey B, Lina B, Bourdon JC, Marcel V, Boivin G, Rosa-Calatrava M, Terrier O.

J Virol. 2019 Mar 21;93(7). pii: e02168-18. doi: 10.1128/JVI.02168-18. Print 2019 Apr 1.

29.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
30.

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.

Fage C, Abed Y, Checkmahomed L, Venable MC, Boivin G.

Viruses. 2018 Dec 22;11(1). pii: E6. doi: 10.3390/v11010006.

31.

Prevalence of a nematode castrator of the carrot weevil and impact on fecundity and survival.

Gagnon AÈ, Boivin G, Bélair G, Mimee B.

Parasitology. 2018 Dec 20:1-6. doi: 10.1017/S0031182018002056. [Epub ahead of print]

PMID:
30567618
32.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

PMID:
30508064
33.

Molecular and epidemiologic investigation of a rhinovirus outbreak in a neonatal intensive care unit.

El Idrissi KR, Isabel S, Carbonneau J, Lafond M, Quach C, Caya C, Fontela PS, Beltempo M, Boivin G, Lefebvre MA, Papenburg J.

Infect Control Hosp Epidemiol. 2019 Feb;40(2):245-247. doi: 10.1017/ice.2018.311. Epub 2018 Dec 5.

PMID:
30516128
34.

Variables Reflecting the Mineralization of Bone Tissue From Fracturing Versus Nonfracturing Postmenopausal Nonosteoporotic Women.

Rizzo S, Farlay D, Akhter M, Boskey A, Recker R, Lappe J, Boivin G.

JBMR Plus. 2018 Jun 20;2(6):323-327. doi: 10.1002/jbm4.10062. eCollection 2018 Nov.

35.
36.

Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.

Abed Y, Tu V, Carbonneau J, Checkmahomed L, Venable MC, Fage C, Marie-Ève-Hamelin, Dufresne SF, Kobinger G, Boivin G.

Antiviral Res. 2018 Nov;159:26-34. doi: 10.1016/j.antiviral.2018.09.007. Epub 2018 Sep 13.

PMID:
30219318
37.

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Bolduc M, Baz M, Laliberté-Gagné MÈ, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D.

Nanomedicine. 2018 Nov;14(8):2563-2574. doi: 10.1016/j.nano.2018.08.010. Epub 2018 Sep 5.

PMID:
30193813
38.

Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.

Lê BV, Jandrot-Perrus M, Couture C, Checkmahomed L, Venable MC, Hamelin MÈ, Boivin G.

J Gen Virol. 2018 Oct;99(10):1367-1380. doi: 10.1099/jgv.0.001135. Epub 2018 Aug 10.

PMID:
30102144
39.

Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis.

Canivet C, Rhéaume C, Lebel M, Piret J, Gosselin J, Boivin G.

J Neurovirol. 2018 Dec;24(6):761-768. doi: 10.1007/s13365-018-0666-9. Epub 2018 Aug 9.

PMID:
30094631
40.

Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization.

de La Vega MA, Piret J, Griffin BD, Rhéaume C, Venable MC, Carbonneau J, Couture C, das Neves Almeida R, Tremblay RR, Magalhães KG, Park YK, Roberts CC, Maslow JN, Sardesai NY, Kim JJ, Muthumani K, Weiner DB, Kobinger GP, Boivin G.

J Infect Dis. 2019 Jan 9;219(3):365-374. doi: 10.1093/infdis/jiy336.

41.

Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.

Boivin G, Kalambaden P, Faget J, Rusakiewicz S, Montay-Gruel P, Meylan E, Bourhis J, Lesec G, Vozenin MC.

Front Oncol. 2018 Jul 9;8:256. doi: 10.3389/fonc.2018.00256. eCollection 2018.

42.

Ovigeny index increases with temperature in an aphid parasitoid: Is early reproduction better when it is hot?

Moiroux J, Boivin G, Brodeur J.

J Insect Physiol. 2018 Aug - Sep;109:157-162. doi: 10.1016/j.jinsphys.2018.06.001. Epub 2018 Jun 2.

PMID:
29870689
43.

Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.

Tu V, Abed Y, Fage C, Baz M, Boivin G.

Antiviral Res. 2018 Jun;154:110-115. doi: 10.1016/j.antiviral.2018.04.009. Epub 2018 Apr 16.

PMID:
29674164
44.

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.

Dempster DW, Brown JP, Fahrleitner-Pammer A, Kendler D, Rizzo S, Valter I, Wagman RB, Yin X, Yue SV, Boivin G.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2498-2509. doi: 10.1210/jc.2017-02669.

45.

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Martín-López J, Gasparini P, Coombes K, Croce CM, Boivin GP, Fishel R.

Oncotarget. 2017 Dec 31;9(16):12554-12561. doi: 10.18632/oncotarget.23792. eCollection 2018 Feb 27.

46.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
47.

Plane Wave SH₀ Piezoceramic Transduction Optimized Using Geometrical Parameters.

Boivin G, Viens M, Belanger P.

Sensors (Basel). 2018 Feb 10;18(2). pii: E542. doi: 10.3390/s18020542.

48.
49.

Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.

Piret J, Carbonneau J, Rhéaume C, Baz M, Boivin G.

J Gen Virol. 2018 Feb;99(2):209-218. doi: 10.1099/jgv.0.000992. Epub 2018 Jan 3.

PMID:
29297844
50.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

Supplemental Content

Loading ...
Support Center